Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of Colorado”
401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8007787
Human cystathionine β-synthase variants and methods of production thereof
granted -
US 8007804
Complement receptor 2 targeted complement modulators
granted -
US 7999082
Anti-factor B antibodies
granted -
US 7993648
Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody
granted -
US 7976851
Non-toxic biofilm inhibitor
granted -
US 7915285
Method for treating drug and behavioral addictions
granted -
US 7862811
Protease inhibition for prevention or treatment of heart failure
granted -
US 7858349
Anti-cancer compounds
granted -
US 7850970
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
granted -
US 7838571
Photopolymers and use in dental restorative materials
granted -
US 7807781
Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections
granted -
US 7763259
Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
granted -
US 7759304
Targeting complement factor H for treatment of diseases
granted -
US 7749490
Mutant IL-10
granted -
US 7750121
Antibody to telomerase reverse transcriptive
granted -
US 7678824
Methods for treatment with bucindolol based on genetic targeting
granted -
US 7622549
Human telomerase reverse transcriptase polypeptides
granted -
US 7595060
Yeast-antigen compositions methods of making the same
granted -
US 7585622
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
granted -
US 7560265
Compositions for regulation of tumor necrosis factor-alpha
granted -
US 7560437
Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
granted -
US 7517971
Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
granted -
US 7510710
Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
granted -
US 7485307
Human cystathionine β-synthase variants and methods of production thereof
granted